← FDA Drug Approvals (Drugs@FDA)

CAVHANZA

NDA · New Drug Application · Sponsor: CYCLE · Approved 2026-05-29

Drug application

FDA Application #

NDA217379

Application type

New Drug Application

Brand name

CAVHANZA

Generic name

NILOTINIB

Active ingredients

NILOTINIB

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Prescription

Sponsor

CYCLE

Manufacturer

Cycle Pharmaceuticals Ltd

First approval

2026-05-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown